10.1089/rej.2008.0717
the pool containing Arg 34 GLP-1 (7-37) and the truncated form, Arg 34 GLP-1 (9-37) , as an impurity was adjusted to pH 3.1, and 5 ml of the resulting solution was applied to a 20 ml Source 30S (Amersham Pharmacia Biotech) column equilibrated with 100 ml 0.85 % (w/w) tri-sodium citrate, 0.33 % (w/w) succinic acid, 0.6 % (w/w) di-sodium hydrogen phosphate di-hydrate, 45 % (w/w) ethanol, pH 3.2
Rentesi G, Antoniou K, Marselos M, Syrrou M, Papadopoulou-Daifoti Z, Konstandi M
Patients can also switch to tirzepatide-based protocols if semaglutide side effects persist
The court was unpersuaded
Some individuals may not respond to NAC, and benefits, if any, are likely to be modest compared to established interventions